Intracolonic infusion of bile salt stimulates release of peptide YY and inhibits cholecystokinin-stimulated pancreatic exocrine secretion in conscious dogs.
The purpose of this study was to examine the effect of transanal (intracolonic) infusion of bile acid on release of peptide YY (PYY) and cholecystokinin (CCK)-stimulated pancreatic exocrine secretion in seven conscious dogs. CCK-8 (50 ng/kg/h) was given intravenously for 120 min and either taurocholic acid (TA, 1 or 2 mmol/h) or saline was infused transanally (150 ml/h) during the 0-60-min period of CCK infusion. Transanal infusion of TA (1 or 2 mmol/h) significantly inhibited output of CCK-8-stimulated pancreatic protein, compared to transanal infusion of saline during the first 60 min. On the average, the magnitude of inhibition was approximately 45%. Plasma concentrations of PYY increased significantly in response to intracolonic infusion of TA or saline. Transanal infusion of TA (1 or 2 mmol/h) significantly increased plasma levels of PYY when compared with transanal infusion of saline during the first 60 min. The magnitude of the increase of plasma PYY levels was approximately 50 pg/ml (p less than 0.05). Plasma levels of pancreatic polypeptide were not altered significantly by transanal infusion of TA. Our results suggest that release of endogenous PYY by TA in the colon plays a role in the inhibition of CCK-stimulated pancreatic exocrine secretion. Bile salts in the hindgut may participate in the physiologic regulation of pancreatic exocrine secretion by stimulation of release of ilealcolonic PYY.
Izukura
M
M
Department of Surgery, University of Texas Medical Branch, Galveston 77550.
Hashimoto
T
T
Gomez
G
G
Uchida
T
T
Greeley
G H
GH
Thompson
J C
JC
D000818:Animals; D001647:Bile Acids and Salts / Q000008:administration & dosage / Q000494:pharmacology* / Q000502:physiology; D002766:Cholecystokinin / Q000494:pharmacology*; D003106:Colon; D004285:Dogs; D005260:Female; D007263:Infusions, Parenteral; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D010191:Pancreatic Polypeptide / Q000097:blood; D019894:Peptide YY; D010455:Peptides / Q000097:blood*; D011863:Radioimmunoassay; D013656:Taurocholic Acid / Q000494:pharmacology
D001647:Bile Acids and Salts; D010455:Peptides; D019894:Peptide YY; D010191:Pancreatic Polypeptide; D013656:Taurocholic Acid; D002766:Cholecystokinin